Clinical trial
A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First…
NCT00001122 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001122 |
|---|---|
| Title | A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly |
| Official title | A Phase II, Randomized, Open-Label Study of Maximally Assisted Therapy (MAT) Compared to Self-Administered Therapy (SAT) for the Treatment of HIV Infection in Antiretroviral Naive Subjects With CD4 Greater Than or Equal to 200 Cells/mm3 |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Nelfinavir mesylate, Efavirenz, Stavudine, Didanosine |
| Enrollment | 74 |
| Primary completion | Oct 1, 2003 |
| First posted | Aug 31, 2001 |
| Last update posted | Mar 2, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: